Ribavirin to Enhance Hepatitis B Virus Nucleotide Analog Antiviral Activity

NCT03759782 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Hepatitis B, Chronic

Interventions

DRUG: Ribavirin
DRUG: Tenofovir

Sponsor

Ottawa Hospital Research Institute